International hair loss experts reached consensus on low-dose oral minoxidil for alopecia in adults and adolescents, but not children under 12, in a modified Delphi study.
"No one ever trades in a Rolls Royce—they just maintain the one they have," quipped pioneering dermatologist Lowell Goldsmith after cardiac surgery, exemplifying the wit and wisdom that marked his 57-year career advancing dermatologic medicine.
Delta variant infections carried double to triple the autoimmune disease risk compared to Omicron, with notable increases in systemic lupus erythematosus (AHR, 2.50), ulcerative colitis (AHR, 2.47), and alopecia totalis (AHR, 2.51), a South Korean study of 6.9 million participants found.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Squamous cell carcinoma is the leading cause of mortality in severe epidermolysis bullosa," notes Dr. Robert Kirsner, as FDA grants rare pediatric designation to mitochondrial-targeting therapy.
In a 7-patient case series, low-dose naltrexone (3 mg daily) reduced nail lichen planus severity by 35% and improved two cases from severe to mild disease, while requiring no discontinuations due to adverse effects.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.